SLC25A4 results significantly upregulated in 2 cancer tissues and significantly downregulated in 14 cancer tissues, out of the 21 “tumor vs. normal” tissue pairs (Figure 1, upper panel). This evidence concerns the gene SLC25A4 and neoplasm.